Health & Nutrition
Eli Lilly blows past estimates, hikes guidance as Zepbound,...
The success of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro...
Eating to Lower Lp(a)
What should we eat—and not eat—to lower the cardiovascular disease risk factor lipoprotein(a)?...
Novo Nordisk shares dip as Wegovy maker posts earnings...
Novo Nordisk on Wednesday announced its second quarter earnings for 2024.
Healthy Returns: What drugmakers are saying about final...
Drugmakers appear to be less concerned about the impact of negotiated prices on...
CVS slashes profit guidance, will cut $2 billion in expenses...
CVS said higher medical costs are weighing on its insurance business, and announced...
How to Treat High Lp(a), an Atherosclerosis Risk Factor
What could help explain severe coronary disease in someone with a healthy lifestyle...
Eli Lilly's Zepbound and Mounjaro now available in U.S....
Demand for weight loss and diabetes drugs has trounced supply for months, pushing...
Moderna stock falls 20% as it slashes guidance on low EU...
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5...
23andMe CEO Anne Wojcicki files proposal to take company...
23andMe CEO Anne Wojcicki has submitted a proposal to take the genetic testing company...
Biogen beats expectations, hikes outlook as Alzheimer's...
Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking...
+Japan+x+Black+Rock+Press+Release_30+July+2024.jpg&h=630&w=1200&q=100&v=5f99a4b43f&c=1)